The GSK-3 inhibitors SB-415286 and lithium as well as arsenic trioxide inactivated GSK-3beta in AML (APL) cells by inducing the phosphorylation of S9 on GSK-3beta [290]. This evidence concerns the gene GSK3B and acute myeloid leukemia.